CSNK1D and metastatic malignant neoplasm in the lymph nodes: Furthermore, we observed higher mRNA levels of CSNK1D in HNSCC patients with a higher pathological grade and at advanced clinical stage than those with the low grade and at an early stage, which was also observed in HNSCC patients with lymph node metastasis (Fig. 1e).